Fe3+ IMAC was not a novel technique nor was its application to phosphorylated protein enrichment, however, its use to identify phosphorylated antigen peptides started a long and impactful effort to discover cancer-specific phosphorylated MHC peptides (35, 36). The gene discussed is HLA-C; the disease is cancer.